Access Scientific, LLC, Awarded Intalere Choice® Agreement for POWERWAND™ Line of Catheters

Wednesday, January 25, 2017 Medical PDA News J E 4

SAN DIEGO, Jan. 25, 2017 /PRNewswire/ -- Access Scientific, a privately held medical device manufacturer of the "evidence based, best in class" POWERWAND catheters, was awarded an agreement with Intalere as a supplier of its valued Intalere Choice program.

Intalere is a leading group purchasing and total cost management organization that serves 3,716 acute care facilities nationwide along with 37,356 clinics and 11,598 long term care facilities. For premium products, Intralere offers Intalere Choice to provide their members the highest quality medical products in growing sectors such as vascular access. The agreement became effective Dec. 1, 2016.

The agreement provides Intalere Choice member facilities access to Access Scientific's proprietary line of POWERWAND catheters, which have demonstrated unparalleled performance in clinical outcomes:

  • 3Fr, 4Fr and 5Fr (16Ga, 17Ga and 19Ga) catheter offering
  • Reduce overall central lines and central line days
  • 12,000 catheter-days with no bloodstream infection
  • Highest flow rates
  • Excellent blood drawability
  • Cost savings (clinical and material)

The POWERWAND line of catheters has been proven to help facilities reduce central line days and CLABSIs while improving quality care at a lower cost, all of which are core to value-based purchasing.

"The Access team looks forward to partnering with Intalere and their members to improve patient care and lower the overall cost of care through implementation of our evidence-based Powerwand products and processes," said Phil Royston, President of Access Scientific.

About Access Scientific, LLC 

Access Scientific is dedicated to the development and commercialization of breakthrough, proprietary devices that make vascular access safer for patients and reduce the cost of care. The company pioneered the power-injectable midline market with the POWERWAND™. Made of proprietary ChronoFlex™ C, the POWERWAND midline has been the proven, evidence based, best-in-class, with over 12,000 catheter-days of published scientific data attesting to the lowest complication rate and highest completion-of-therapy rate of any vascular access device ever studied. The POWERWAND offers a unique approach to reducing hospital-acquired infections. Visit to learn more.

Contact: Liz Dowling, (415) 388-2794 Dowling & Dennis Public Relations E-mail:


To view the original version on PR Newswire, visit:

SOURCE Access Scientific, LLC



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Ropack Pharma Solutions Selects TraceLink to Achie...
GenomeDx's Decipher Biopsy Demonstrates Ability to...